Hypotension from afatinib in epidermal growth factor receptor-mutated non-small cell lung cancer: a case report and literature review

Side effects of afatinib are a problem in patients with advanced non-small cell lung cancer (NSCLC). However, little is known about the occurrence of afatinib-induced hypotension. An 81-year-old man with NSCLC had an epidermal growth factor receptor-positive genotype with the p.L861Q mutation in exo...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Zhiwei, Ji, XiuHai, Zhou, Guanghui, Chen, Ruhua, Fen, Yan, Ding, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670351/
https://www.ncbi.nlm.nih.gov/pubmed/34486535
http://dx.doi.org/10.1097/CAD.0000000000001244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670351/
https://www.ncbi.nlm.nih.gov/pubmed/34486535
http://dx.doi.org/10.1097/CAD.0000000000001244

Ejemplares similares